International Stem Cell Corp. (ISCO)

[236T568]

Oh, my....its the same guy, the Russian ISCO Chief Scientific Officer

but quick - lets go and attempt to change the appearance:


and here you have a November 2016 picture at a benefit using his original Russian name, Ruslan Semechkin, 14 months after the alleged name change to Russell Kern:


http://www.ranchosantafereview.com/cm-cm-rowecap-12-20161108-photo.html



by the way, this is the way the Russian Scientist looked two years earlier:

https://www.facebook.com/InternationalStemCellCorporation/photos/pb.172262287089.-2207520000.1450653306./10152294326682090/?type=3&theater



and a more conservative look:

https://www.researchgate.net/profile/Ruslan_Semechkin

Who is ISCO Chief Scientific Officer Russell Kern

and

Who is ISCO Chief Scientific Officer Ruslan Semechkin


ISCO 2018 Proxy Statement

https://www.sec.gov/Archives/edgar/data/1355790/000156459018009811/isco-def14a_20180621.htm
Russell Kern, Ph.D, Director, Executive Vice President and Chief Scientific Officer, became a Director in October 2008. Dr. Kern has served as our Chief Scientific Officer since June 2013 and previously served since December 2008 in various scientific and management positions, including as Vice President Research and Development. Dr. Kern was trained in medical genetics, embryology and stem cell biology. He holds a Ph.D. degree in Human Physiology from the Russian Academy of Medical Sciences and has broad expertise in neuroscience, and was part of the team, along with scientists from the NYU Medical School that elucidated the physiological changes that occur in the brains of Parkinson’s disease patients. Dr. Kern directs ISCO’s R&D programs including stem cell derivation, differentiation and the pre-clinical and clinical evaluation of stem cell derived cells and tissue. He has developed a general method of deriving highly pure populations of neural stem cells and dopaminergic neurons from pluripotent stems cells that is novel, practical and suitable for use in a clinical setting. Dr. Kern is a well-known speaker on stem cell biology, including the use of stem cells for neurology and skin regeneration. He has more than 40 publications in the field of Parkinson’s disease and stem cell biology and he is an active member of the American Academy of Neurology and the Society for Neuroscience. Dr. Russell Kern is the son of Dr. Andrey Semechkin, our Co-Chairman and Chief Executive Officer.



ISCO 2015 Proxy Statement

https://www.sec.gov/Archives/edgar/data/1355790/000119312515112507/d894841ddef14a.htm
Ruslan Semechkin, Ph.D, Director, Chief Scientific Officer, became a Director in October 2008. Dr. Semechkin was trained in medical genetics, stem cell biology and international business administration, and holds an M.S. degree from Faculty of Fundamental Medicine of Moscow State University. He earned his Ph.D. degree in Physiology from Anokhin Research Institute of Normal Physiology, Russian Academy of Medical Sciences. Dr. Semechkin is a well-known speaker on stem cell biology, including the use of stem cells for neurology and skin regeneration. He has publications in the field of clinical and molecular biology, and is author of various patent applications. Dr. Ruslan Semechkin is the son of Dr. Andrey Semechkin, our Co-Chairman and Chief Executive Officer.